Lincoln Pharmaceuticals consolidated net profit declines 56.89% in the June 2017 quarter

Sales rise 51.26% to Rs 134.86 crore

Net profit of Lincoln Pharmaceuticals declined 56.89% to Rs 4.91 crore in the quarter ended June 2017 as against Rs 11.39 crore during the previous quarter ended June 2016. Sales rose 51.26% to Rs 134.86 crore in the quarter ended June 2017 as against Rs 89.16 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales134.8689.16 51 OPM %5.2116.94 -PBDT8.2516.52 -50 PBT6.8715.14 -55 NP4.9111.39 -57

Powered by Capital Market - Live News